Oriola in Russia

OOO Oriola is one of the leading (Top 6) wholesale pharmaceutical distributors in Russia. The company operates in most of Russian regions, it has established 12 branches across the country. The head office and main distribution centre are located in Moscow area.

 

Oriola has more than 15 years of experience and substantial business competence on Russian pharmaceutical market. Before March 28th, 2011 the company's name was FC Moron. After 100% acquisition by Oriola-KD the company rebranded to Oriola.

Our services

Oriola provides wholesale trade and distribution services to more than 20 000 customer delivery points across Russia. Main distribution hub with own transport facilities and 12 regional distribution centers contribute to growing business volume and coverage. We provide  the following key services to our customers and partners:

  • full scope of logistics and warehouse services
  • flexible options for convenient methods of placing orders
  • product delivery at preferred time and place
  • 24/7 order-picking facilities
  • customized  approach to collecting related documents
  • pharmaceutical produce import services
  • personal manager to support a customer
  • range of services to support product sales and marketing
  • exclusive distribution of consumer health products

Our quality

State legislation gives directives, how the pharmaceuticals shall be manufactured and treated through the value chain. Oriola complies with all necessary special guidelines locally and seeks to follow the international Good Distribution Practice (GDP), which is a minimum standard for distribution companies. Oriola is audited externally by local authorities and principal medical companies on regular basis. On top of that the company implements internal Quality programs, based on  corporate level projects developed by all Oriola companies in order to support corporate business strategy.

  

Our strategy

Oriola is positioned as a strong and reliable cross-regional wholesale distributor on the Russian pharmaceutical market. Strategic directions for the company include:

  • the consolidation and development of  Oriola brand on Russian market
  • increasing economic and operating business efficiency
  • enlargening market share in Russia regions of Oriola presence
  • optimizing and strengthening commercial department
  • improving the quality of services and operations

As a part of Oriola-KD, Oriola in Russia operates in accordance with the strategic vision Group is a unique pharmaceutical channel in Northern Europe and Russia.

 

Our partners 

Oriola key partners include Russian and foreign pharmaceutical manufactures, consumer health product suppliers, large pharmacy chains as well as small pharmacies, hospitals and other medical institutions.

Key figures 2010

  • Net sales EUR 518,4 million
  • Personnel 1600